Quadrature Capital’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$565K Buy
+6,075
New +$538K 0.01% 751
2022
Q3
Sell
-6,709
Closed -$368K 836
2022
Q2
$368K Buy
+6,709
New +$389K 0.02% 488
2021
Q1
Sell
-7,313
Closed -$213K 844
2020
Q4
$213K Sell
7,313
-11,545
-61% -$299K 0.01% 704
2020
Q3
$415K Buy
18,858
+5,534
+42% +$141K 0.02% 514
2020
Q2
$370K Buy
+13,324
New +$325K 0.04% 440
2018
Q1
Sell
-17,780
Closed -$510K 574
2017
Q4
$510K Buy
+17,780
New +$559K 0.05% 327
2017
Q3
Sell
-18,153
Closed -$380K 422
2017
Q2
$380K Buy
+18,153
New +$384K 0.03% 405

Other funds holding ACLS

Quadrature Capital's ACLS Position: Q1 2026 in Review

Quadrature Capital opened a new position in Axcelis (ACLS) in Q1 2026: 6,075 shares worth $565K. The stake represents 0.01% of the portfolio and ranks #751 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in ACLS as recently as Q2 2022.

Quadrature Capital first reported a position in ACLS in Q2 2017 and has held it in 7 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Quadrature Capital held 6,075 shares of Axcelis worth $565K as of Q1 2026.
  • Axcelis was a new Quadrature Capital position in Q1 2026.
  • Axcelis made up 0.01% of Quadrature Capital's portfolio in Q1 2026, its #751 holding.
  • Quadrature Capital first reported a position in Axcelis in Q2 2017 and has held it in 7 quarters since.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.